Results 221 to 230 of about 89,996 (262)
Some of the next articles are maybe not open access.

Steatohepatitis in children

Best Practice & Research Clinical Gastroenterology, 2002
Steatohepatitis in children occurs in the childhood version of non-alcoholic fatty liver disease (NAFLD), as a result of hepatotoxicity and with certain genetic/metabolic diseases. Until recently, NAFLD was considered to be rare in children. It is now recognized as an important childhood liver disease, especially because childhood obesity is much more ...
openaire   +2 more sources

Nonalcoholic Steatohepatitis

Seminars in Liver Disease, 1999
Nonalcoholic steatohepatitis (NASH) is an hepatic disorder with histologic features of alcohol-induced liver disease that occurs in individuals who do not consume significant alcohol. NASH is believed to be one of the most common explanations for abnormal liver chemistries in American adults.
openaire   +2 more sources

Nonalcoholic Steatohepatitis in Children

Journal of Pediatric Gastroenterology and Nutrition, 2000
ABSTRACTBackground:Nonalcoholic steatohepatitis occurs commonly in adults with obesity or diabetes mellitus. There are only a few reports of this condition in children.Methods:Prospective consecutive clinical series.Results:Between December 1985 and April 1995, 36 children (21 boys, 15 girls) were diagnosed with nonalcoholic steatohepatitis at the ...
M, Rashid, E A, Roberts
openaire   +2 more sources

Nonalcoholic Steatohepatitis in Children

Clinics in Liver Disease, 2022
Nonalcoholic fatty liver disease (NAFLD) is the leading cause of chronic liver disease in children. Although environmental factors are major contributors to early onset, children have both shared and unique genetic risk alleles as compared with adults with NAFLD. Treatment relies on reducing environmental risk factors, but many children have persistent
openaire   +2 more sources

Non-alcoholic steatohepatitis

Medicina ClĂ­nica (English Edition), 2022
Non-alcoholic steatohepatitis belongs to the spectrum of metabolic-associated fatty liver diseases characterized by steatosis linked to obesity, diabetes, metabolic syndrome, dyslipidemia and immune-mediated disorders. The main features of MAFLD include high prevalence, heterogeneity, complexity and dynamic disease.
openaire   +3 more sources

Nonalcoholic steatohepatitis

Gastroenterology, 2001
Nonalcoholic steatohepatitis (NASH) is a condition characterized by hepatomegaly, elevated serum aminotransferase levels, and a histologic picture similar to alcoholic hepatitis in the absence of alcohol abuse. Most patients with NASH are obese women, and many have diabetes mellitus, hypercholesterolemia, or hypertriglyceridemia.
openaire   +2 more sources

Mitochondrial injury in steatohepatitis

European Journal of Gastroenterology & Hepatology, 2004
Rich diet and lack of exercise are causing a surge in obesity, insulin resistance and steatosis, which can evolve into steatohepatitis. Patients with non-alcoholic steatohepatitis have increased lipid peroxidation, increased tumour necrosis factor-alpha (TNF-alpha) and increased mitochondrial beta-oxidation rates. Their in-vivo ability to re-synthesize
Dominique, Pessayre   +2 more
openaire   +2 more sources

Pathogenesis of nonalcoholic steatohepatitis

Cellular and Molecular Life Sciences, 2016
Nonalcoholic steatohepatitis (NASH) is a severe form of nonalcoholic fatty liver disease and a risk factor for cirrhosis and hepatocellular carcinoma. The pathological features of NASH include steatosis, hepatocyte injury, inflammation, and various degrees of fibrosis. Steatosis reflects disordered lipid metabolism.
Wensheng, Liu   +4 more
openaire   +2 more sources

Non-alcoholic Steatohepatitis in Children

Clinics in Liver Disease, 2003
Non-alcoholic steatohepatitis (NASH) is an important liver disease in children; it can cause cirrhosis in children. The disease mechanism involves hepatic insulin resistance with hyperinsulinemia and changes in certain adipocytokines and inflammatory mediators.
openaire   +3 more sources

Drug-induced steatohepatitis

Clinics in Liver Disease, 2003
Drugs rarely cause steatohepatitis, but amiodarone, perhexiline, and DH, have unequivocally been found to independently induce the histologic picture of alcoholic liver disease or NASH. All three agents have similar pathogenetic mechanisms of hepatotoxicity, targeting mitochondrial ATP production and fatty acid catabolism. Other drugs that occasionally
R Todd, Stravitz, Arun J, Sanyal
openaire   +2 more sources

Home - About - Disclaimer - Privacy